Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ramadan

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic PathwaysHelal F Hetta, Tameem Melhem, Hashim M Aljohani, et al.
Molecules (Basel, Switzerland)|August 10, 2024
Quorum Sensing Inhibitors: An Alternative Strategy to Win the Battle against Multidrug-Resistant (MDR) BacteriaHelal F Hetta, Yasmin N Ramadan, Zainab I Rashed, et al.
Diagnostics (Basel, Switzerland)|May 27, 2026
Human Metapneumovirus (HMPV): Advances in Diagnosis, Molecular Epidemiology, and Clinical Impact of an Underrecognized Respiratory VirusHelal F Hetta, Rehab Ahmed, Abdul Haseeb, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Antimicrobial Peptides: The Game-Changer in the Epic Battle Against Multidrug-Resistant BacteriaHelal F Hetta, Nizar Sirag, Shumukh M Alsharif, et al.
CNS Neuroscience & Therapeutics|September 21, 2021
Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorderMahmoud S Abdallah, Ahmed N Ramadan, Hend Omara-Reda, et al.
Health Science Reports|April 23, 2024
Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive reviewHelal F Hetta, Alaa Elsaghir, Victor Coll Sijercic, et al.
AMB Express|September 22, 2023
COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challengesRehab Mahmoud Abd El-Baky, Esraa R Shady, Ramadan Yahia, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Artificial Sweeteners: A Double-Edged Sword for Gut MicrobiomeHelal F Hetta, Nizar Sirag, Hassabelrasoul Elfadil, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Diagnostic Innovations to Combat Antibiotic Resistance in Critical Care: Tools for Targeted Therapy and StewardshipAhmed D Alatawi, Helal F Hetta, Mostafa A Sayed Ali, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Antiviral Drugs in HIV and Cardiovascular Disease: Mechanistic Insights and Clinical ImplicationsHelal F Hetta, Fawaz E Alanazi, Hanan Alshareef, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic PathwaysHelal F Hetta, Tameem Melhem, Hashim M Aljohani, et al.
Molecules (Basel, Switzerland)|August 10, 2024
Quorum Sensing Inhibitors: An Alternative Strategy to Win the Battle against Multidrug-Resistant (MDR) BacteriaHelal F Hetta, Yasmin N Ramadan, Zainab I Rashed, et al.
Diagnostics (Basel, Switzerland)|May 27, 2026
Human Metapneumovirus (HMPV): Advances in Diagnosis, Molecular Epidemiology, and Clinical Impact of an Underrecognized Respiratory VirusHelal F Hetta, Rehab Ahmed, Abdul Haseeb, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Antimicrobial Peptides: The Game-Changer in the Epic Battle Against Multidrug-Resistant BacteriaHelal F Hetta, Nizar Sirag, Shumukh M Alsharif, et al.
CNS Neuroscience & Therapeutics|September 21, 2021
Double-blind, randomized, placebo-controlled pilot study of the phosphodiesterase-3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorderMahmoud S Abdallah, Ahmed N Ramadan, Hend Omara-Reda, et al.
Health Science Reports|April 23, 2024
Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive reviewHelal F Hetta, Alaa Elsaghir, Victor Coll Sijercic, et al.
AMB Express|September 22, 2023
COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challengesRehab Mahmoud Abd El-Baky, Esraa R Shady, Ramadan Yahia, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Artificial Sweeteners: A Double-Edged Sword for Gut MicrobiomeHelal F Hetta, Nizar Sirag, Hassabelrasoul Elfadil, et al.
Diagnostics (Basel, Switzerland)|September 13, 2025
Diagnostic Innovations to Combat Antibiotic Resistance in Critical Care: Tools for Targeted Therapy and StewardshipAhmed D Alatawi, Helal F Hetta, Mostafa A Sayed Ali, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Antiviral Drugs in HIV and Cardiovascular Disease: Mechanistic Insights and Clinical ImplicationsHelal F Hetta, Fawaz E Alanazi, Hanan Alshareef, et al.
Pageof 6